Sodium sulfadiazine
CAS No. 547-32-0
Sodium sulfadiazine ( —— )
产品货号. M18781 CAS No. 547-32-0
Sodium Sulfadiazine 是磺胺嘧啶的钠盐形式,磺胺嘧啶是一种中效抑菌的合成磺胺衍生物。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Sodium sulfadiazine
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Sodium Sulfadiazine 是磺胺嘧啶的钠盐形式,磺胺嘧啶是一种中效抑菌的合成磺胺衍生物。
-
产品描述Sodium Sulfadiazine is a sodium salt form of sulfadiazine, an intermediate-acting bacteriostatic, synthetic sulfanilamide derivative.(In Vivo):In this study, the effectiveness of Sulfadiazine sodium and Pyrimetamine for the treatment of mice during acute infection with different atypical T. gondii strains was evaluated. Swiss mice were infected with seven T. gondii strainsl. The infected mice were treated with 10-640?mg/kg per day of Sulfadiazine sodium, 3-200?mg/kg per day of Pyrimetamine, or a combination of both drugs with a lower dosage. A descriptive analysis was used to assess the association between susceptibility to sodium and/or Pyrimetamine and the genotype. The TgCTBr4 and TgCTBr17 strains (genotype 108) presented lower susceptibility to sodium or Pyrimetamine treatment. The TgCTBr1 and TgCTBr25 strains (genotype 206) presented similar susceptibility to PYR but not sodium treatment. The TgCTBr9 strain (genotype 11) was the only strain with high susceptibility to treatment with both drugs .
-
体外实验——
-
体内实验In this study, the effectiveness of Sulfadiazine sodium and Pyrimetamine for the treatment of mice during acute infection with different atypical T. gondii strains was evaluated. Swiss mice were infected with seven T. gondii strainsl. The infected mice were treated with 10-640?mg/kg per day of Sulfadiazine sodium, 3-200?mg/kg per day of Pyrimetamine, or a combination of both drugs with a lower dosage. A descriptive analysis was used to assess the association between susceptibility to sodium and/or Pyrimetamine and the genotype. The TgCTBr4 and TgCTBr17 strains (genotype 108) presented lower susceptibility to sodium or Pyrimetamine treatment. The TgCTBr1 and TgCTBr25 strains (genotype 206) presented similar susceptibility to PYR but not sodium treatment. The TgCTBr9 strain (genotype 11) was the only strain with high susceptibility to treatment with both drugs .
-
同义词——
-
通路Metabolic Enzyme/Protease
-
靶点Retinoid Receptor
-
受体Others
-
研究领域Others-Field
-
适应症——
化学信息
-
CAS Number547-32-0
-
分子量272.26
-
分子式C10H10N4O2S·Na
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 125 mg/mL (459.12 mM)
-
SMILESNC1=CC=C(C=C1)S(=O)(=O)N([Na])C1=NC=CC=N1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
021-51111890
购物车()
sales@molnova.cn

